Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer
- 31 August 2012
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Disease Mechanisms
- Vol. 9 (1-2), e41-e46
- https://doi.org/10.1016/j.ddmec.2012.10.002
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Catechol metabolites of zeranol and 17β-estradiol: A comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferaseToxicology Letters, 2012
- Catechol-O-methyltransferase Val158Met polymorphism in breast cancer riskBreast Cancer Research and Treatment, 2011
- Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancerJournal of Gynecologic Oncology, 2011
- Candidate Genes and Mechanisms for 2-Methoxyestradiol–Mediated VasoprotectionHypertension, 2010
- COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studiesBreast Cancer Research and Treatment, 2010
- Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controlsBreast Cancer Research and Treatment, 2009
- Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic PolymorphismsCancer Research, 2008
- Catechol-O-methyltransferase: Effects of the val108met polymorphism on protein turnover in human cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Inhibition of catechol-O-methyltransferase increases estrogen–DNA adduct formationFree Radical Biology & Medicine, 2007
- Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancersJournal of Steroid Biochemistry, 1989